Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin vs Diclofenac for Postoperative Analgesia After Surface Ablation
NCT06752486Phase 1Recruiting
- Sponsor
- Research Institute of Ophthalmology
- Start
- Dec 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of gabapentin in postoperative pain (2 arms), sponsored by Research Institute of Ophthalmology. Primary endpoint: Visual Analog Scale at 72 hours. Started Dec 2024; status: recruiting.
02
Drugs
gabapentin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06752486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06752486.